Induction of labour at 41 weeks of gestation versus expectant management and induction of labour at 42 weeks of gestation: a cost‐effectiveness analysis

Induction Of Labour ◽

Expectant Management vs. Prompt Delivery for Severe Preeclampsia Diagnosed 30-33 weeks: A Week-by-Week Cost-Effectiveness Analysis

10.1016/j.ajog.2021.11.301 ◽

2022 ◽

Vol 226 (1) ◽

pp. S172

Author(s):

Olivia Curl ◽

Claire H. Packer ◽

Sarina R. Chaiken ◽

Uma Doshi ◽

Aaron B. Caughey

Keyword(s):

Cost Effectiveness ◽

Expectant Management ◽

Severe Preeclampsia ◽

20: Induction of labor versus expectant management at 39 weeks: a cost-effectiveness analysis

10.1016/j.ajog.2018.11.023 ◽

2019 ◽

Vol 220 (1) ◽

pp. S18

Author(s):

Alyssa R. Hersh ◽

Ashley E. Skeith ◽

James A. Sargent ◽

Aaron B. Caughey

Keyword(s):

Cost Effectiveness ◽

Expectant Management ◽

Induction Of Labor ◽

Induction of labour using balloon catheter as an outpatient versus prostaglandin as an inpatient: a cost-effectiveness analysis.

10.22541/au.159363418.81114593 ◽

2020 ◽

Author(s):

Katharina Merollini ◽

Michael Beckmann

Keyword(s):

Cost Effectiveness ◽

Balloon Catheter ◽

Induction Of Labour ◽

Comparing induction of labour with oral misoprostol or Foley catheter at term: cost-effectiveness analysis of a randomised controlled multi-centre non-inferiority trial

BJOG An International Journal of Obstetrics & Gynaecology ◽

10.1111/1471-0528.14706 ◽

2017 ◽

Vol 125 (3) ◽

pp. 375-383 ◽

Cited By ~ 5

Author(s):

MLG ten Eikelder ◽

G-J van Baaren ◽

K Oude Rengerink ◽

M Jozwiak ◽

JW de Leeuw ◽

...

Keyword(s):

Cost Effectiveness ◽

Foley Catheter ◽

Induction Of Labour ◽

Effectiveness Analysis ◽

Oral Misoprostol ◽

Randomised Controlled

Expectant management of preterm premature rupture of membranes at 34 weeks: a cost effectiveness analysis

The Journal of Maternal-Fetal & Neonatal Medicine ◽

10.1080/14767058.2021.2017874 ◽

2021 ◽

pp. 1-9

Author(s):

Jacqueline M. Powell ◽

Zoë C. Frank ◽

Grace V. Clark ◽

Jamie O. Lo ◽

Aaron B. Caughey

Keyword(s):

Cost Effectiveness ◽

Expectant Management ◽

Premature Rupture Of Membranes ◽

Premature Rupture ◽

Preterm Premature Rupture ◽

323 Selective fetoscopic laser or expectant management for quintero stage i twin-twin transfusion: a cost-effectiveness analysis

10.1016/j.ajog.2020.12.344 ◽

2021 ◽

Vol 224 (2) ◽

pp. S212-S213

Author(s):

Jordan Stone ◽

Aimen Shaaban ◽

William A. Grobman ◽

Ashish Premkumar

Keyword(s):

Cost Effectiveness ◽

Expectant Management ◽

Stage I ◽

Cost-effectiveness analysis of prostaglandin E2 gel for the induction of labour at term

BJOG An International Journal of Obstetrics & Gynaecology ◽

10.1111/j.1471-0528.2011.02902.x ◽

2011 ◽

Vol 118 (6) ◽

pp. 726-734 ◽

Cited By ~ 12

Author(s):

S Petrou ◽

SE Taher ◽

G Abangma ◽

O Eddama ◽

P Bennett

Keyword(s):

Cost Effectiveness ◽

Prostaglandin E2 ◽

Induction Of Labour ◽

Induction of labor at 39 weeks of gestation versus expectant management for low-risk nulliparous women: a cost-effectiveness analysis

10.1016/j.ajog.2019.02.017 ◽

2019 ◽

Vol 220 (6) ◽

pp. 590.e1-590.e10 ◽

Cited By ~ 19

Author(s):

Alyssa R. Hersh ◽

Ashley E. Skeith ◽

James A. Sargent ◽

Aaron B. Caughey

Keyword(s):

Cost Effectiveness ◽

Expectant Management ◽

Induction Of Labor ◽

Low Risk ◽

Effectiveness Analysis ◽

Nulliparous Women

Uncertainty in evidence synthesis limits clinical applicability of a clinical and cost-effectiveness analysis of induction of labour methods

Evidence-Based Medicine ◽

10.1136/ebmed-2016-110552 ◽

2016 ◽

Vol 21 (6) ◽

pp. 226-226

Author(s):

Christina Davidson

Keyword(s):

Cost Effectiveness ◽

Evidence Synthesis ◽

Induction Of Labour ◽

Clinical Applicability ◽

Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies

Clinical Pharmacology & Therapeutics ◽

10.1016/s0009-9236(96)90060-0 ◽

1996 ◽

Vol 60 (3) ◽

pp. 332-340 ◽

Cited By ~ 57

Author(s):

M DEGATTA ◽

M CALVO ◽

J HERNANDEZ ◽

D CABALLERO ◽

J SANMIGUEL ◽

...

Keyword(s):

Cost Effectiveness ◽

Hematologic Malignancies ◽

Vancomycin Concentration ◽

Effectiveness Analysis ◽

Serum Vancomycin